117 related articles for article (PubMed ID: 37143202)
1. Modeling the Effects of IL-1β-mediated Inflammation During Ex Vivo Lung Perfusion Using a Split Human Donor Model.
Pither T; Wang L; Bates L; Morrison M; Charlton C; Griffiths C; Macdonald J; Bigley V; Mavridou M; Barsby J; Borthwick L; Dark J; Scott W; Ali S; Fisher AJ
Transplantation; 2023 Oct; 107(10):2179-2189. PubMed ID: 37143202
[TBL] [Abstract][Full Text] [Related]
2. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.
Andreasson ASI; Borthwick LA; Gillespie C; Jiwa K; Scott J; Henderson P; Mayes J; Romano R; Roman M; Ali S; Fildes JE; Marczin N; Dark JH; Fisher AJ;
J Heart Lung Transplant; 2017 Sep; 36(9):985-995. PubMed ID: 28551353
[TBL] [Abstract][Full Text] [Related]
3. Pro-IL-1β Is an Early Prognostic Indicator of Severe Donor Lung Injury During Ex Vivo Lung Perfusion.
Major T; Ball AL; Stone JP; Edge RJ; Lopez-Castejon G; Sjöberg T; Andreasson A; Brough D; Steen S; Fisher AJ; Fildes JE
Transplantation; 2021 Apr; 105(4):768-774. PubMed ID: 32976365
[TBL] [Abstract][Full Text] [Related]
4. Male versus female inflammatory response after brain death model followed by ex vivo lung perfusion.
Ricardo-da-Silva FY; Armstrong-Jr R; Ramos MMA; Vidal-Dos-Santos M; Jesus Correia C; Ottens PJ; Moreira LFP; Leuvenink HGD; Breithaupt-Faloppa AC
Biol Sex Differ; 2024 Jan; 15(1):11. PubMed ID: 38287395
[TBL] [Abstract][Full Text] [Related]
5. Profiling inflammation and tissue injury markers in perfusate and bronchoalveolar lavage fluid during human ex vivo lung perfusion.
Andreasson AS; Karamanou DM; Gillespie CS; Özalp F; Butt T; Hill P; Jiwa K; Walden HR; Green NJ; Borthwick LA; Clark SC; Pauli H; Gould KF; Corris PA; Ali S; Dark JH; Fisher AJ
Eur J Cardiothorac Surg; 2017 Mar; 51(3):577-586. PubMed ID: 28082471
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo rehabilitation of non-heart-beating donor lungs in preclinical porcine model: delayed perfusion results in superior lung function.
Mulloy DP; Stone ML; Crosby IK; Lapar DJ; Sharma AK; Webb DV; Lau CL; Laubach VE; Kron IL
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1208-15. PubMed ID: 22944084
[TBL] [Abstract][Full Text] [Related]
7. Transplant Suitability of Rejected Human Donor Lungs With Prolonged Cold Ischemia Time in Low-Flow Acellular and High-Flow Cellular Ex Vivo Lung Perfusion Systems.
Okamoto T; Wheeler D; Farver CF; McCurry KR
Transplantation; 2019 Sep; 103(9):1799-1808. PubMed ID: 30801532
[TBL] [Abstract][Full Text] [Related]
8. Cytokine expression profile in human lungs undergoing normothermic ex-vivo lung perfusion.
Sadaria MR; Smith PD; Fullerton DA; Justison GA; Lee JH; Puskas F; Grover FL; Cleveland JC; Reece TB; Weyant MJ
Ann Thorac Surg; 2011 Aug; 92(2):478-84. PubMed ID: 21704971
[TBL] [Abstract][Full Text] [Related]
9. L-alanyl-L-glutamine modified perfusate improves human lung cell functions and extend porcine ex vivo lung perfusion.
Huang L; Hough O; Vellanki RN; Takahashi M; Zhu Z; Xiang YY; Chen M; Gokhale H; Shan H; Soltanieh S; Jing L; Gao X; Wouters BG; Cypel M; Keshavjee S; Liu M
J Heart Lung Transplant; 2023 Feb; 42(2):183-195. PubMed ID: 36411189
[TBL] [Abstract][Full Text] [Related]
10. Optimal ex vivo lung perfusion techniques with oxygenated perfusate.
Noda K; Tane S; Haam SJ; Hayanga AJ; D'Cunha J; Luketich JD; Shigemura N
J Heart Lung Transplant; 2017 Apr; 36(4):466-474. PubMed ID: 27914896
[TBL] [Abstract][Full Text] [Related]
11. Composition of
Radomsky L; Koch A; Olbertz C; Liu Y; Beushausen K; Keil J; Rauen U; Falk CS; Kühne JF; Kamler M
Front Cardiovasc Med; 2023; 10():1245618. PubMed ID: 37808880
[TBL] [Abstract][Full Text] [Related]
12. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.
Machuca TN; Cypel M; Zhao Y; Grasemann H; Tavasoli F; Yeung JC; Bonato R; Chen M; Zamel R; Chun YM; Guan Z; de Perrot M; Waddell TK; Liu M; Keshavjee S
J Heart Lung Transplant; 2015 Jun; 34(6):849-57. PubMed ID: 25907141
[TBL] [Abstract][Full Text] [Related]
13. Ex Vivo Perfusion With Adenosine A2A Receptor Agonist Enhances Rehabilitation of Murine Donor Lungs After Circulatory Death.
Stone ML; Sharma AK; Mas VR; Gehrau RC; Mulloy DP; Zhao Y; Lau CL; Kron IL; Huerter ME; Laubach VE
Transplantation; 2015 Dec; 99(12):2494-503. PubMed ID: 26262504
[TBL] [Abstract][Full Text] [Related]
14. Impact of imipenem concentration in lung perfusate and tissue biopsy during clinical ex-vivo lung perfusion of high-risk lung donors.
Fanelli V; Del Sorbo L; Boffini M; Costamagna A; Balzano S; Musso T; Scutera S; Cappello P; Mazzeo A; Solidoro P; Baietto L; D'avolio A; Derosa FG; Brazzi L; Mascia L; Rinaldi M; Ranieri VM
Minerva Anestesiol; 2020 Jun; 86(6):617-626. PubMed ID: 31994367
[TBL] [Abstract][Full Text] [Related]
15. Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion.
Machuca TN; Cypel M; Yeung JC; Bonato R; Zamel R; Chen M; Azad S; Hsin MK; Saito T; Guan Z; Waddell TK; Liu M; Keshavjee S
Ann Surg; 2015 Mar; 261(3):591-7. PubMed ID: 25371129
[TBL] [Abstract][Full Text] [Related]
16. Treatment with 3-aminobenzamide during ex vivo lung perfusion of damaged rat lungs reduces graft injury and dysfunction after transplantation.
Wang X; Parapanov R; Debonneville A; Wang Y; Abdelnour-Berchtold E; Gonzalez M; Gronchi F; Perentes JY; Ris HB; Eckert P; Piquilloud L; Lugrin J; Letovanec I; Krueger T; Liaudet L
Am J Transplant; 2020 Apr; 20(4):967-976. PubMed ID: 31710417
[TBL] [Abstract][Full Text] [Related]
17. Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs.
Nakajima D; Cypel M; Bonato R; Machuca TN; Iskender I; Hashimoto K; Linacre V; Chen M; Coutinho R; Azad S; Martinu T; Waddell TK; Hwang DM; Husain S; Liu M; Keshavjee S
Am J Transplant; 2016 Apr; 16(4):1229-37. PubMed ID: 26730551
[TBL] [Abstract][Full Text] [Related]
18. Acellular ex vivo lung perfusate silences pro-inflammatory signaling in human lung endothelial and epithelial cells.
Jeon JE; Huang L; Zhu Z; Wong A; Keshavjee S; Liu M
J Transl Med; 2023 Oct; 21(1):729. PubMed ID: 37845763
[TBL] [Abstract][Full Text] [Related]
19. Targeting Circulating Leukocytes and Pyroptosis During Ex Vivo Lung Perfusion Improves Lung Preservation.
Noda K; Tane S; Haam SJ; D'Cunha J; Hayanga AJ; Luketich JD; Shigemura N
Transplantation; 2017 Dec; 101(12):2841-2849. PubMed ID: 28452921
[TBL] [Abstract][Full Text] [Related]
20. Functional, Metabolic and Morphologic Results of Ex Vivo Donor Lung Perfusion with a Perfluorocarbon-Based Oxygen Carrier Nanoemulsion in a Large Animal Transplantation Model.
Inci I; Arni S; Iskender I; Citak N; Rodriguez JM; Weisskopf M; Opitz I; Weder W; Frauenfelder T; Krafft MP; Spahn DR
Cells; 2020 Nov; 9(11):. PubMed ID: 33218154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
